Venbio Select Advisor Has Upped By $6.31 Million Its Vanda Pharmaceuticals (VNDA) Stake; PHH (PHH) Has 0.8 Sentiment

April 22, 2018 - By Ellis Scott

PHH Corp (PHH) investors sentiment decreased to 0.8 in Q4 2017. It’s down -0.12, from 0.92 in 2017Q3. The ratio fall, as 44 hedge funds started new and increased stock positions, while 55 cut down and sold their equity positions in PHH Corp. The hedge funds in our database now own: 30.80 million shares, up from 30.18 million shares in 2017Q3. Also, the number of hedge funds holding PHH Corp in top ten stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 13 Reduced: 42 Increased: 23 New Position: 21.

Venbio Select Advisor Llc increased Vanda Pharmaceuticals Inc (VNDA) stake by 42.57% reported in 2017Q4 SEC filing. Venbio Select Advisor Llc acquired 420,676 shares as Vanda Pharmaceuticals Inc (VNDA)’s stock rose 9.54%. The Venbio Select Advisor Llc holds 1.41 million shares with $21.42 million value, up from 988,270 last quarter. Vanda Pharmaceuticals Inc now has $756.43 million valuation. The stock increased 0.68% or $0.1 during the last trading session, reaching $14.85. About 519,914 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 15.63% since April 22, 2017 and is uptrending. It has outperformed by 4.08% the S&P500.

Among 8 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 24 analyst reports since September 2, 2015 according to SRatingsIntel. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has “Buy” rating given on Wednesday, October 21 by Brean Capital. Oppenheimer maintained the shares of VNDA in report on Sunday, November 12 with “Buy” rating. Oppenheimer maintained the shares of VNDA in report on Monday, October 30 with “Outperform” rating. The firm earned “Buy” rating on Wednesday, February 28 by Seaport Global. JMP Securities maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Friday, August 26. JMP Securities has “Market Outperform” rating and $22 target. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) earned “Buy” rating by Oppenheimer on Monday, January 8. On Monday, September 4 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Jefferies given on Tuesday, February 13. The firm has “Buy” rating by Jefferies given on Monday, June 26. The firm earned “Buy” rating on Thursday, October 6 by Jefferies.

Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.26, from 1.43 in 2017Q3. It fall, as 19 investors sold VNDA shares while 34 reduced holdings. 16 funds opened positions while 46 raised stakes. 39.77 million shares or 2.28% more from 38.89 million shares in 2017Q3 were reported. Glenmede Trust Na holds 0% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) for 574 shares. Natl Bank Of Montreal Can invested in 0% or 71,855 shares. Prelude Cap Management invested in 950 shares. Jpmorgan Chase And holds 379,829 shares. Us Financial Bank De, Minnesota-based fund reported 3,224 shares. Cubist Systematic Strategies Ltd Llc accumulated 0% or 2,357 shares. State Of Wisconsin Board owns 33,000 shares or 0% of their US portfolio. Delaware-based Dupont Capital Mngmt has invested 0.03% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Deutsche Commercial Bank Ag invested in 112,712 shares or 0% of the stock. Comml Bank Of America Corporation De stated it has 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Dekabank Deutsche Girozentrale invested in 0% or 11,100 shares. Kistler has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Moreover, First Mercantile Trust has 0.02% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) for 6,860 shares. Geode Management Ltd owns 399,046 shares. Clarivest Asset Mngmt Limited Liability Corporation owns 45,999 shares or 0.01% of their US portfolio.

Since January 2, 2018, it had 0 insider buys, and 8 insider sales for $4.89 million activity. The insider Gulino Richard L. sold $68,473. Birznieks Gunther sold $130,777 worth of stock. The insider Kelly James Patrick sold 9,155 shares worth $140,494. Polymeropoulos Mihael Hristos sold $2.93M worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Tuesday, January 2.

Silver Point Capital L.P. holds 1.87% of its portfolio in PHH Corporation for 1.76 million shares. Goldentree Asset Management Lp owns 436,202 shares or 0.49% of their US portfolio. Moreover, Hutchin Hill Capital Lp has 0.34% invested in the company for 119,718 shares. The California-based Menta Capital Llc has invested 0.27% in the stock. Rbf Capital Llc, a California-based fund reported 74,626 shares.

Since January 1, 0001, it had 0 buys, and 2 selling transactions for $97,578 activity.

Analysts await PHH Corporation (NYSE:PHH) to report earnings on May, 8. They expect $-0.89 EPS, up 28.23% or $0.35 from last year’s $-1.24 per share. After $-1.44 actual EPS reported by PHH Corporation for the previous quarter, Wall Street now forecasts -38.19% EPS growth.

PHH Corporation (NYSE:PHH) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: